Ken Fisher Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Fisher Asset Management, LLC

  • $243 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022
SELL
$83.14 - $145.99 $30.6 Million - $53.8 Million
-368,257 Closed
0 $0
Q1 2022

May 05, 2022
SELL
$110.08 - $142.92 $471,252 - $611,840
-4,281 Reduced 1.15%
368,257 $43.7 Million
Q4 2021

Feb 02, 2022
BUY
$99.73 - $148.48 $10.4 Million - $15.5 Million
104,562 Added 39.02%
372,538 $51.3 Million
Q3 2021

Oct 26, 2021
BUY
$98.85 - $138.91 $26.5 Million - $37.2 Million
267,976 New
267,976 $37.2 Million

Others Institutions Holding BHVN

# of Institutions
11
Shares Held
792K
Call Options Held
0
Put Options Held
0
View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

BHVN Quotes by TradingView
  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $2.8B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track Ken Fisher's Portfolio

Track Ken Fisher Portfolio

Follow Ken Fisher (Fisher Asset Management, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fisher Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fisher Asset Management, LLC and Ken Fisher with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email